RATED: Mdys/S&P/Fitch rate Bormioli Pharma E350m sr sec FRN B3/B-/B
HYC European Market: Deal Flow - General
Moody's/S&P/Fitch rate Bormioli Pharma SpA
(BORMPH) EUR350m 144A/Reg S sr sec FRN due 2028 (5y) B3/B-/B (stable/stable/stable - revised from negative). Via BNP/GS+.